· Master of Laws, University of Minnesota

 · Bachelor of Laws, Korea National Open University

 · Ph.D. in Pharmacy, College of Pharmacy, Chung-Ang University

 · Master of Pharmacy, College of Pharmacy, Chung-Ang University

 · Bachelor of Pharmacy, College of Pharmacy, Chung-Ang University

 · Partner, PHIL & ONZI

 · Counselor in Biotechnology and Pharmaceuticals, UNITEF, Ministry of Science & Technology

 · Senior researcher, SK Chemicals

 · Senior researcher, PIKE Co., LTD.

 · Research Scientist, Daewoong Pharmaceuticals Co., LTD.

Theses (3 in total)

 · “Formulation Study on Olmesartan Prodrug”, Ph.D. Thesis, Chung-Ang University, Seoul, Korea, 2012

 · “Research, Administrative Approval and Patent Protection in the field of Stem Cell”, Patent Attorney Papers, Training Institute, Seoul, Korea, 2003

 · “Buoyant Matrix Formulations of Cefaclor with PEO and Their Drug Release Kinetics”, Master Degree Thesis, Chung-Ang University, Seoul, Korea, 1997

Research Papers (5 in total)

 · “Design, Synthesis, Bioconversion, and Pharmacokinetics Evaluation of New Ester”, European Journal of Medicinal Chemistry 46 (2011) 3564-3569

 · “Novel Amides and Esters Prodrugs of Olmesartan: Synthesis, Bioconversion, and Pharmacokinetic Evaluation”, Bioorganic & Medicinal Chemistry Letters 20 (2010) 5895–5899

 · “Comparison of Protein Precipitation Method and Solid Phase Extraction Method for Sample Pretreatment”, Chung-Ang journal of pharmacal sciences 11 (1997) 33-40

 · “Preparation of Cefaclor-Containing Gelatin Microcapsules and Their Drug Release Characteristics”, Yakhak Hoeji 41 (1997) 30-37

 · “Glibenclamide Release Characteristics

Patent Applications (11 in total)

 · “Amlodipine Gentisate, and Process for Preparing it”, Korean Patent No. 10-841409, 2004

 · “Controlled Release Matrix Tablet Containing Cefaclor and Method for Manufacturing the same”, Korean Patent No. 10-0313972, 1997 

 · Korea Patent Attorneys Association, APAA, D.C. Bar Association